| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate |
1997-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c936aba9540766999d068d1f13918ad9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd391ca9ffca9b2b782852ec41ad2f62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d71c292f3d7d671d76d0e5a711bd2045 |
| publicationDate |
2001-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-332292-A |
| titleOfInvention |
Use of 2-phenyl-1,2 benzisoselenazol-3(2H)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease |
| abstract |
The use of 2-phenyl-1,2-benzisoselenazol-3(2H)-one for producing a pharmaceutical preparation for the prophylaxis and/or therapy of dementia, senile dementia or Alzheimer-type dementia. The effect of the drug is based on the action of reducing neuron toxicity induced by beta-amyloid protein. |
| priorityDate |
1996-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |